Not Yet Recruiting PHASE1 INTERVENTIONAL 2-arm
NCT07470125
Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers
An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Bioequivalence of YHP2511 With YHP2511A in Healthy Adult Volunteers
Sponsor: Yuhan Corporation
Conditions
Healthy Subjects
Updated 1 time since 2026 Last updated: Mar 10, 2026 Started: Jun 23, 2026 Primary completion: Jul 11, 2026 Completion: Jul 11, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07470125, this PHASE1 trial focuses on Healthy Subjects and remains actively recruiting participants. Sponsored by Yuhan Corporation, it has been updated 1 time since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Yuhan Corporation
Data source: Yuhan Corporation
For direct contact, visit the study record on ClinicalTrials.gov .